Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle - Wikidata - wikimedia - TriplyDB

Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle

Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle

http://www.wikidata.org/entity/Q36633131

about

Secretion of amyloidogenic gelsolin progressively compromises protein homeostasis leading to the intracellular aggregation of proteins Immunization with amyloid-beta attenuates inclusion body myositis-like myopathology and motor impairment in a transgenic mouse model Scanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory Myopathies Targeting protein homeostasis in sporadic inclusion body myositis.Immunotherapies for Immune-Mediated Myopathies: A Current Perspective Magnesium ion influx reduces neuroinflammation in Aβ precursor protein/Presenilin 1 transgenic mice by suppressing the expression of interleukin-1β.Immune and myodegenerative pathomechanisms in inclusion body myositis Aberrant cell cycle reentry in human and experimental inclusion body myositis and polymyositis Nonimmune mechanisms of muscle damage in myositis: role of the endoplasmic reticulum stress response and autophagy in the disease pathogenesis.Inclusion body myositis: laser microdissection reveals differential up-regulation of IFN-γ signaling cascade in attacked versus nonattacked myofibers.Theories of the pathogenesis of inclusion body myositis.Calpain inhibition attenuates intracellular changes in muscle cells in response to extracellular inflammatory stimulation.Proteomic study of sporadic inclusion body myositis.Type 1 interferons and myositis.Therapeutic advances and future prospects in immune-mediated inflammatory myopathies.Autoantibodies produced at the site of tissue damage provide evidence of humoral autoimmunity in inclusion body myositis.TNF-alpha induces macroautophagy and regulates MHC class II expression in human skeletal muscle cells.Cell stress molecules in the skeletal muscle of GNE myopathy.Neuroinflammation and neuronal loss precede Aβ plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease.Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis.The vitamin D receptor agonist BXL-01-0029 as a potential new pharmacological tool for the treatment of inflammatory myopathies Th1 response and systemic treg deficiency in inclusion body myositis.Molecular treatment effects of alemtuzumab in skeletal muscles of patients with IBM.Mitochondrial dysfunction in skeletal muscle of amyloid precursor protein-overexpressing mice.Cytokine inhibition in chronic fatigue syndrome patients: study protocol for a randomized controlled trial.The blockage of the Nogo/NgR signal pathway in microglia alleviates the formation of Aβ plaques and tau phosphorylation in APP/PS1 transgenic mice.Increased Expression of the NOD-like Receptor Family, Pyrin Domain Containing 3 Inflammasome in Dermatomyositis and Polymyositis is a Potential Contributor to Their Pathogenesis.The NLRP3 Inflammasome as a novel player of the intercellular crosstalk in metabolic disorders.Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer's and Parkinson's disease brains.Is TNF a link between aging-related reproductive endocrine dyscrasia and Alzheimer's disease?Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis.Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositis.IL-1β-Induced Accumulation of Amyloid: Macroautophagy in Skeletal Muscle Depends on ERK.Sporadic inclusion body myositis: variability in prevalence and phenotype and influence of the MHC.Foxo/atrogin induction in human and experimental myositis.Review: An update on inflammatory and autoimmune myopathies.Tumor necrosis factor-alpha as a potential therapeutic target in idiopathic inflammatory myopathies.Oxidative stress and β-amyloid protein in Alzheimer's disease.Targeted immunotherapy trials for idiopathic inflammatory myopathies.T cells in myositis.

P2860

Q24338969-1F8FE632-CC7B-4442-A901-F3F76785D097 Q24608911-C31D2332-5E44-4B18-A571-0EDA6F14F04B Q26798209-67B34A40-5D2B-4EEE-9B05-C35AE929C030 Q27324564-7171120B-DE55-4C12-B750-D611F8A82510 Q30699742-1A4DCB3C-5B9E-4B16-9F34-EBF38A63F647 Q33652107-0A17E2D7-AF8A-45E4-A138-5EF50D3BB93C Q33753870-731FA096-DD54-4C53-8D06-4BE77AB1FCF5 Q33784450-55DBC490-BCC6-40C0-9B35-D388F197B0A9 Q33880537-40FF01C5-F5F9-46F4-B608-F1E32EFDF39C Q33998204-2843EAAB-8F85-486D-AA03-56B4A90DCC79 Q34090910-BB41184E-3054-4C98-BCF3-80F2FBA060C2 Q34175815-6DB5C6F4-6740-46BC-91DC-49D1EC91E8E9 Q34234305-E966F541-667D-44B5-B5BD-51DC714E2F7B Q34350190-B81239EC-5687-431C-B884-07005A9572D0 Q34409105-29357D60-2137-462B-AC71-CA41446BAE70 Q34447370-B65D400A-9D0A-4724-8400-33DAF61E3A4C Q34537114-8CD713DF-B416-4D22-819A-B60B7FBAE16D Q34622146-4127038E-F2D3-41B3-BD00-657EA5BB6CFC Q34656208-1889C7C3-0685-415F-8FBA-6A8C379F4D71 Q34661859-4CCECFF8-DCAD-43AB-9582-CE523DD3BE4F Q35035562-B2D35899-813B-439F-8B06-1B15F0FC1DDA Q35110718-786B19B0-66C7-4DD3-8906-465F7B95788B Q35991443-0AC6F6AF-D46A-4031-A757-EB09B6BB86BF Q36016957-A7309100-B222-4C21-A458-D53F92120740 Q36126508-C44507AF-A1DC-4235-9366-EA92C10E148B Q36646116-687982AA-6E7D-4856-8402-2BE761E9FD01 Q36856554-90A2F926-E288-4956-B7B4-7F92A2C0E93D Q36971550-FAFCBDF3-2E8F-475F-B450-AA81FD8C6F76 Q37083992-7C6FDDBD-704F-4B8A-9E81-62A732A88DA8 Q37120749-7802ACD7-7A6A-4FAE-B6A1-8F185E0520C7 Q37201405-C7E08B84-215D-40A6-B531-82AD7D1164A4 Q37366124-C6CB55DA-C48A-40E1-B181-14D766514AE1 Q37607376-05C91A2B-CC31-4F1B-907E-A70D128D619B Q37686467-A0E6DE92-38E0-4385-9AFC-ACE3B3E28622 Q37701112-0738D95A-4DB9-402F-B473-0698B03C6CE3 Q37820692-3C43FDDD-B49B-4CCC-9B24-863F2F039FF5 Q37831189-5586F508-BF1F-4CCC-B47A-F92AE8D19225 Q37928994-DB5B63B2-9343-4326-9005-6A181A2429B5 Q38023207-4C47AC2D-A8B8-4C0A-89B2-847596DB77F6 Q38070033-1668AF96-EE21-4FEB-AB59-784E624B9D0F

P2860

Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle

http://www.wikidata.org/entity/Q36633131

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Interrelation of inflammation ...... eta-amyloid in skeletal muscle

@ast

Interrelation of inflammation ...... eta-amyloid in skeletal muscle

@en

type

label

Interrelation of inflammation ...... eta-amyloid in skeletal muscle

@ast

Interrelation of inflammation ...... eta-amyloid in skeletal muscle

@en

prefLabel

Interrelation of inflammation ...... eta-amyloid in skeletal muscle

@ast

Interrelation of inflammation ...... eta-amyloid in skeletal muscle

@en

P1433

Q36633131-9217FDEB-857D-4CF5-A410-38295093E609

P1476

Q36633131-9F8431D9-3847-4A17-9A08-6202034571D4

P2093

Q36633131-23626CFE-4F90-4C75-B5E4-23DCE13DD3F3

Q36633131-4873A4BA-BD99-4B4C-B37B-750DD1C822F8

Q36633131-7E2F3046-E230-42D2-B898-89292FEFBD74

Q36633131-AC7FA4A3-649E-4113-9F2D-7D9792EBD3B7

Q36633131-BB18E20A-7652-4EBE-815C-44EA74CD4215

Q36633131-D98C50F3-8669-45EC-B13B-C834A173AE31

P2860

Q36633131-0856C280-F502-480C-8696-A2797EBDBFFB

Q36633131-0CCF643E-2E90-4AA9-9E27-BE87F9F9107A

Q36633131-0E49416A-65F5-49ED-BCE3-AE38046A38F3

Q36633131-125621CF-36E6-44F2-9986-1EFC2A2B0F02

Q36633131-14D3EC69-9D1F-42AB-B72B-13657AF916C1

Q36633131-14E8D5F7-B90B-41A1-9A91-CD94FBCE9803

Q36633131-1DD902E6-899E-420F-B2F6-04A9E3C0AFC3

Q36633131-1DDBACEF-506B-4304-A384-B75ED49B52B4

Q36633131-2D42DB19-77B9-4EDB-9D47-B5F3C0AB6B53

Q36633131-3B29814A-1E57-4814-A711-429DC872D24C

P304

Q36633131-7A4A47AC-D152-4B64-944D-4F745C156E3D

P31

Q36633131-30F3CC22-65E8-4669-8C88-8D32E9AFF899

P356

Q36633131-3808FD9C-6D4F-4A6A-BDCE-CBE71D3AD8F6

P407

Q36633131-0A9E29BF-9A71-4E29-AC0F-114A1219DFA6

P433

Q36633131-4CA03C17-A406-4FE7-87B2-D06FDB1079F6

P478

Q36633131-1ABC1B9D-49C6-4288-912F-93DD8C8F0DE3

P577

Q36633131-959F6D5D-BDCA-46B5-A8B8-3A2DA98D73E5

P5875

Q36633131-98AEAE46-4BE0-4D1E-B1F6-9ACDEA26FF9D

P698

Q36633131-61A9E503-015F-4CC4-9869-5DFB98BCC7E2

P932

Q36633131-C9EC62E2-5B27-4780-85C1-C6DFFDC9BBFC

P356

P1433

P1476

Interrelation of inflammation ...... eta-amyloid in skeletal muscle

@en

P2093

Arne Wrede

http://www.w3.org/2001/XMLSchema#string

Jens Schmidt

http://www.w3.org/2001/XMLSchema#string

Konstanze Barthel

http://www.w3.org/2001/XMLSchema#string

Marinos C Dalakas

http://www.w3.org/2001/XMLSchema#string

Mathias Bähr

http://www.w3.org/2001/XMLSchema#string

Mohammad Salajegheh

http://www.w3.org/2001/XMLSchema#string

P2860

Transfer of beta-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle

Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition.

Polymyositis and dermatomyositis.

Sporadic inclusion body myositis--diagnosis, pathogenesis and therapeutic strategies.

Chemokine profile of different inflammatory myopathies reflects humoral versus cytotoxic immune responses.

TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle

Genetically augmenting Abeta42 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice.

Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy.

Transgenic mice over-expressing the C-99 fragment of betaPP with an alpha-secretase site mutation develop a myopathy similar to human inclusion body myositis.

Immunobiology of muscle: advances in understanding an immunological microenvironment.

P304

1228-1240

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWN053

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 5

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5431418

http://www.w3.org/2001/XMLSchema#string

P698

18420712

http://www.w3.org/2001/XMLSchema#string

P932

2367696

http://www.w3.org/2001/XMLSchema#string